What is the recommended workup for thrombocytopenia?

Thrombocytopenia Workup

For any patient with thrombocytopenia, immediately obtain a complete blood count with peripheral blood smear to exclude pseudothrombocytopenia, then proceed with HIV and HCV testing while evaluating for emergency conditions requiring urgent intervention.

Initial Essential Steps

1. Confirm True Thrombocytopenia

• Exclude pseudothrombocytopenia first by redrawing blood in heparin or sodium citrate tube 1
• This is critical as EDTA-dependent platelet clumping can falsely lower platelet counts
• Review the peripheral blood smear personally

2. Determine Acuity

Distinguish acute from chronic thrombocytopenia by reviewing previous platelet counts 1

• Acute thrombocytopenia may require immediate hospitalization
• Emergency conditions requiring urgent recognition:
  • Thrombotic microangiopathy (TMA)
  • Disseminated intravascular coagulation (DIC)
  • Heparin-induced thrombocytopenia (HIT)
  • HELLP syndrome in pregnancy 2, 1

Core Diagnostic Workup

Mandatory Initial Tests (Grade 1B)

The ASH 2019 guidelines strongly recommend testing all patients for:

• HIV testing 3
• HCV testing 3

These are essential regardless of risk factors or geographic location, as both can present with isolated thrombocytopenia.

Essential Clinical Evaluation 4

Patient History - specifically inquire about:

• Drug exposures (prescription, over-the-counter, herbal supplements, quinine/tonic water)
• Alcohol use and liver disease history
• Recent infections or vaccinations
• Autoimmune conditions (SLE, antiphospholipid syndrome)
• HIV/HCV risk factors
• Recent transfusions (posttransfusion purpura)
• Family history of bleeding or thrombocytopenia (inherited forms)
• Pregnancy status in women of childbearing age

Physical Examination - look for:

• Bleeding manifestations (petechiae, purpura, mucosal bleeding)
• Splenomegaly (suggests sequestration, portal hypertension, or lymphoproliferative disease)
• Lymphadenopathy (malignancy)
• Stigmata of chronic liver disease

Laboratory Tests of Proven Utility 4

Always obtain:

• Complete blood count with reticulocyte count
• Peripheral blood smear examination (critical for identifying other cytopenias, schistocytes, abnormal cells)
• Quantitative immunoglobulin levels (especially in children with persistent/chronic ITP)
• Direct antiglobulin test (Coombs)

Additional tests based on clinical context:

• Pregnancy test in women of childbearing potential
• Antinuclear antibodies (if autoimmune disease suspected)
• Antiphospholipid antibodies (anticardiolipin, lupus anticoagulant)
• Antithyroid antibodies and thyroid function
• Blood group (Rh status)
• H. pylori testing (recommended for adults) 4
• Viral PCR for parvovirus and CMV (if clinically indicated)

When to Perform Bone Marrow Examination

Bone marrow examination is NOT necessary for typical ITP presentation (Grade 2C) 3

Consider bone marrow biopsy if:

• Abnormalities beyond isolated thrombocytopenia on CBC (anemia, leukopenia, abnormal differential) 3
• Atypical features on peripheral smear
• Age > 60 years (some experts recommend, though not consensus)
• Failure to respond to initial ITP therapy
• Suspicion of myelodysplastic syndrome, leukemia, or bone marrow infiltration

Risk Stratification by Platelet Count 1

• > 50,000/μL: Generally asymptomatic, low bleeding risk
• 20,000-50,000/μL: Mild skin manifestations (petechiae, purpura, ecchymosis)
• < 10,000/μL: High risk of serious bleeding, requires urgent intervention

Critical Pitfalls to Avoid

1. Don't assume ITP without excluding secondary causes - Response to IVIg or steroids does NOT exclude secondary ITP 4

2. Recognize thrombohaemorrhagic syndromes - Some conditions present with thrombocytopenia but have predominant thrombotic risk (HIT, TMA, antiphospholipid syndrome) where bleeding treatment could be catastrophic 2, 5

3. Don't transfuse platelets in ITP or TTP - Prophylactic platelet transfusion is contraindicated in immune thrombocytopenia and thrombotic thrombocytopenic purpura 2

4. Pregnancy requires special consideration - 7-10% of pregnant women develop thrombocytopenia; gestational thrombocytopenia (100-149,000/μL) is benign and requires no workup 6

Algorithm Summary

Thrombocytopenia detected
    ↓
Exclude pseudothrombocytopenia (redraw in heparin/citrate)
    ↓
Review peripheral smear + determine acuity
    ↓
Emergency signs? (TMA/DIC/HIT/HELLP) → Immediate intervention
    ↓
If stable: Obtain HIV, HCV, CBC, smear, history, exam
    ↓
Isolated thrombocytopenia + normal smear → Likely ITP or drug-induced
    ↓
Other cytopenias or abnormal smear → Bone marrow examination
    ↓
Tailor additional testing based on clinical context

The workup should be efficient and targeted - avoid unnecessary tests like platelet-associated IgG, bleeding time, or platelet survival studies, which have uncertain clinical utility 4.